Identify and validate patient stratification biomarkers for ALK inhibitor trials. Develop assays for companion diagnostic (CDx) submissions.
ALK Analysis Services: Deciphering Oncogenic Drivers for Precision Oncology!
Accelerate your precision oncology research and therapeutic development! Are you currently facing challenges in accurately identifying ALK rearrangements, validating fusion partners, or assessing the functional impact of ALK variants in complex tumor samples? Our comprehensive ALK Analysis Services leverage state-of-the-art genomic and molecular profiling platforms to deliver precise, reliable data. We help you uncover critical oncogenic drivers, enabling targeted therapy selection and robust biomarker discovery for improved patient stratification.
Overview of ALK Analysis
The identification of Anaplastic Lymphoma Kinase (ALK) gene alterations, particularly rearrangements, has revolutionized the treatment landscape for non-small cell lung cancer (NSCLC) and other malignancies. However, research and diagnostic development are hindered by the heterogeneity of ALK fusions, the low abundance of fusion transcripts in some samples, and the need for high sensitivity and specificity in complex biological matrices. Comprehensive ALK analysis is not merely about detection; it's about precise characterization to inform therapeutic strategy and understand resistance mechanisms.
| Technical Method | Core Principle | Primary Application in ALK Analysis |
|---|---|---|
| NGS | High-throughput parallel sequencing of DNA/RNA | Comprehensive detection of known/novel ALK fusions, identification of fusion partners, and simultaneous analysis of co-occurring mutations. |
| FISH | Visual detection of gene rearrangements using fluorescent probes | Gold-standard for ALK rearrangement detection, especially in formalin-fixed paraffin-embedded FFPE tissue sections. |
| RT−PCR | Amplification of fusion-specific cDNA sequences | Highly sensitive and rapid detection of specific, common ALK fusion variants. |
| IHC | Detection of ALK fusion protein overexpression | Cost-effective screening tool with rapid turnaround, useful for prescreening samples. |
Fig.1 Structure of ALK.1
How Creative Biolabs' Service Can Assist Your Project?
Creative Biolabs provides an end-to-end ALK analysis solution that transforms your tumor samples into actionable genomic insights. We deliver more than just a positive/negative result; we provide detailed reports on fusion partners, variant allele frequency, and archival of sequencing data for future mining. Our experts help you navigate the complexities of assay selection and data interpretation, ensuring your project， whether for drug discovery companion diagnostic development or clinical research， is built on a foundation of rigorous, reproducible data.
Discover How We Can Help - Request a Consultation!
Service Workflow
Our streamlined workflow is designed for efficiency, transparency, and scientific rigor, guiding your project from sample to strategic insight.
01Project Initiation & Sample Details
Provide sample details (e.g., FFPE tissue blocks, fresh frozen tissue, RNA/DNA extracts) and clinical/research context.
02Assay Selection & Design
Scientists recommend the optimal platform(s) (NGS, FISH, RT-PCR, IHC) based on sample type and objectives.
03Sample Processing & QC
Rigorous checks (e.g., RNA integrity number, DNA concentration) ensure assay validity.
04Platform-Specific Analysis
Execution using optimized protocols and calibrated instrumentation.
05Data Analysis & Interpretation
Advanced bioinformatics for NGS or expert pathologist review for FISH/IHC.
06Final Deliverables
A comprehensive report including status, methodology, raw/analyzed data, and a summary of biological implications.
Applications
Therapeutic Development & CDx Support
Clinical Research & Biomarker Discovery
Correlate ALK fusion variants with clinical outcomes, therapy response, and resistance mechanisms.
Liquid Biopsy Development
Optimize ultra-sensitive NGS assays for detecting ALK fusions and resistance mutations in circulating tumor DNA.
Pathology Laboratory Services Enhancement
Implement and validate robust, high-throughput ALK testing protocols.
Published Data
A pivotal study evaluated multiple ALK detection methodologies in NSCLC. While IHC served as a sensitive screening tool, discordant cases underscored the necessity of confirmatory testing. FISH provided visual confirmation of rearrangement, and RT-PCR offered precise fusion variant identification, but each had limitations in detecting novel partners. This study reinforces the critical value of a complementary, multi-platform strategy to achieve definitive ALK characterization and avoid false negatives.
Why Choose Us?
- Integrated Multi-Platform Strategy: Deploying NGS, FISH, RT-PCR, and IHC for orthogonal validation.
- Expertise in Challenging Samples: Extracting high-quality data from low-input, degraded FFPE tissues.
- Regulatory-Ready Assay Development: Protocols designed to meet standards for pre-clinical and clinical study support.
- Actionable Data Interpretation: Reports curated by scientist-consultants to translate genomic data into biological insights.
Harness the Creative Biolabs Advantage – Connect with Us for a Personalized Quote Today.
Frequently Asked Questions
-
Q: When should I use NGS versus FISH for ALK analysis?
A: NGS is ideal for discovering novel fusion partners and coexisting mutations. FISH is the gold standard for definitive rearrangement detection in tissue sections.
-
Q: Can you analyze ALK status from liquid biopsy samples?
A: Yes. We offer targeted NGS panels optimized for ctDNA to detect ALK fusions and resistance mutations with high sensitivity.
-
Q: What is the minimum sample requirement for RNA-based NGS analysis?
A: We typically work with as little as 10 ng of high-quality RNA. For degraded FFPE samples, we use specialized library prep kits.
-
Q: Do you provide support for assay validation for clinical trials?
A: Yes. We have experience in analytical validation studies including sensitivity, specificity, and precision to support clinical trial endpoints.
-
Q: How do you handle data privacy and confidentiality?
A: All data is handled under strict confidentiality agreements and stored on secure servers in compliance with data protection regulations.
Our popular analysis services targeting ALK include but are not limited to the following:
| Cat | Service |
| BAS95-1 | ALK Protein Analysis |
| BAS95-2 | ALK Mutation Detection |
| BAS95-3 | ALK RNAi Assay |
| BAS95-4 | ALK Inhibitor Development |
| BAS95-5 | ALK Glycosylation Analysis |
| BAS95-6 | ALK Isoform Analysis |
| BAS95-7 | In Vitro Kinase Assay |
| BAS95-8 | ALK Kinase Activity Assay |
Contact Us
Creative Biolabs stands as a premier provider of specialized molecular analysis services for oncology research. Our ALK Analysis Services combine cutting-edge technology with deep scientific expertise to deliver the precise, reliable genomic data you need to drive your precision medicine projects forward. Contact Our Team for More Information and to Discuss Your Project.
Reference
- From Wikipedia: By A2-33 - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/wiki/File:2xp2.png.
For Research Use Only.